All News

Will Nutland, DrPH, is cofounder of PrEPster, an honorary assistant professor at the London School of Hygiene and Tropical Medicine, and an activist.

The Alliance of Community Health Plans (ACHP) recently released its 2021 Report on Affordability. In this episode of Managed Care Cast, we speak with the organization about the steps that its payer members are taking to lower costs through offerings such as virtual-first care, remote patient monitoring, and other new products, some of which were created because of the pandemic.

Cynthia Rice, MPP, JDRF chief mission strategy officer, explains how Build Back Better would affect the cost of insulin.

As the cost of oncology drugs increases, there has been a growing pressure to manage oncology drug spend, which some payers have done by establishing preferred therapies, including biosimilars.

The White House will invest $1.5 billion to bolster the nation's health care workforce; new data reveal long-term Pfizer COVID-19 vaccine efficacy in children; Idaho deactivates crisis standards of care for some portions of the state.

In a study assessing the impacts of 5 growth factors on MS, fibroblast growth factor 23 was identified to increase the risk of patients experiencing the onset and progression of multiple sclerosis (MS).

Treatment strategies focused on dopaminergic regeneration rather than symptomatic relief may transform the way Parkinson disease is managed.

Discussions regarding health equity and access to care have long been implicated in breast cancer. Here, key opinion leaders discuss the latest progress in clinical trial access, digital therapeutics, and other efforts that aim to ameliorate these care gaps.

A new analysis of data from the HOMAGE study addresses previous mixed results on the use of aspirin among patients who may be at risk of heart failure (HF).

Authors of a systematic literature review concluded more research is needed to better understand the financial burden of spinal muscular atrophy (SMA).

A multifaceted approach focused on enforcing basic infection prevention practices and promoting education about Clostridioides difficile (C difficile) transmission led to a reduction in the number of infections in a hospital setting.

The report, based on a survey conducted in Spain, suggests patients are suffering from additional asthma exacerbations due to a lack of understanding of their disease.

REPAIR study findings outline the benefits of macitentan for right ventricular functioning in pulmonary arterial hypertension.

Study findings show those with celiac disease tend to experience migraine more frequently than healthy individuals.

Blood eosinophil count is a promising biomarker and example of the pathway toward precision medicine in chronic obstructive pulmonary disease (COPD), said Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital.

Karen L. van Caulil, PhD, president and CEO of Florida Alliance for Healthcare Value, discusses the potential gap in care that may occur with the end of the Oncology Care Model.

CMS' introduction of 3 new electronic clinical quality measures, 2 of which are focused on inpatient glycemic management, signal a strong commitment to shine a light on this often-overlooked area, according to the chief medical officer at Glytec.

Low- and middle-income countries that hosted completed COVID-19 vaccine trials received disproportionately fewer doses than high-income counterparts; mental health apps indicated to increase uptake in underserved men; CDC report finds notable stillbirth risk in pregnant women with COVID-19.

A new sub-analysis suggested eating foods with anti-inflammatory properties may improve physical functioning in patients with rheumatoid arthritis.

Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association (ADA), describes the ADA's efforts to elevate the conversation about the impact of diabetes on kidney disease.

Preventing addiction is key to ending the opioid epidemic—2020 alone saw more than 93,000 overdose deaths—as are expanding access to treatment, promoting recovery, and building a multifaceted strategy that incorporates nonopioid alternative and their coverage by providers. Although appropriate in certain situations, opioids are not a one-size-fits-all approach.

The decision will provide Medicare coverage tests for minimal residual disease (MRD) starting December 26, 2021.

The prognosis was worse in patients with basic dementia or Alzheimers disease as well as chronic obstructive pulmonary disease or asthma.

Findings presented at the 2021 American College of Rheumatology Annual Meeting showed that patients with concomitant psoriasis and psoriatic arthritis (PsA) reported greater incidence of obesity, hypertension, and diabetes, as well as a higher likelihood of work inability than those with only psoriasis.

Findings from a cross-sectional study revealed a potential link between liver health and inflammatory diet properties.

While research has examined the implications of the immune system and its contributions to pulmonary arterial hypertension, further research is required to understand the pathobiology of the condition.

A report from the Centers for Medicare and Medicaid Innovation confirmed that practices within the US Oncology Network and Tennessee Oncology participating in the Oncology Care Model (OCM) program have contributed significant savings to the agency.

Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, discusses the use of cognitive behavioral therapy (CBT) as a first-line treatment for chronic insomnia and barriers limiting its use.

Funmi Olopade, MD, FACP, professor of medicine and human genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, explains how different populations are at different risk for breast cancer and the importance of informed screening.

Abstracts from American College of Rheumatology Convergence 2021 showed whether gender can impact the effectiveness of secukinumab in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA).